Simplex Trading
ZYME icon

Simplex Trading’s Zymeworks ZYME Stock Holding History

Simplex Trading’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$215K Sell
8,600
-6,000
-41% -$142K ﹤0.01% 4219
2025
Q4 		$384K Buy
14,600
+12,800
+711% +$279K ﹤0.01% 3561
2025
Q3 		$30K Buy
1,800
+400
+29% +$5.72K ﹤0.01% 6996
2025
Q2 		$17K Buy
1,400
+300
+27% +$3.57K ﹤0.01% 6928
2025
Q1 		$13K Buy
1,100
+1,000
+1,000% +$13.6K ﹤0.01% 6947
2024
Q4 		$1K Sell
100
-45,900
-100% -$642K ﹤0.01% 8348
2024
Q3 		$577K Buy
46,000
+9,800
+27% +$107K ﹤0.01% 3445
2024
Q2 		$308K Buy
36,200
+27,200
+302% +$242K ﹤0.01% 4192
2024
Q1 		$94K Buy
9,000
+6,800
+309% +$75.5K ﹤0.01% 5655
2023
Q4 		$22K Sell
2,200
-15,100
-87% -$120K ﹤0.01% 6860
2023
Q3 		$109K Sell
17,300
-82,200
-83% -$607K ﹤0.01% 4995
2023
Q2 		$859K Buy
99,500
+43,000
+76% +$385K ﹤0.01% 2742
2023
Q1 		$510K Buy
56,500
+38,800
+219% +$338K ﹤0.01% 3244
2022
Q4 		$139K Sell
17,700
-33,500
-65% -$235K ﹤0.01% 4683
2022
Q3 		$314K Buy
51,200
+35,100
+218% +$212K ﹤0.01% 4030
2022
Q2 		$85K Buy
16,100
+14,600
+973% +$88.3K ﹤0.01% 5788
2022
Q1 		$9K Buy
1,500
+800
+114% +$7.13K ﹤0.01% 8994
2021
Q4 		$11K Buy
700
+100
+17% +$2.08K ﹤0.01% 8970
2021
Q3 		$22K Hold
600
– – ﹤0.01% 8374
2021
Q2 		$20K Buy
600
+592
+7,400% +$18.8K ﹤0.01% 8599
2021
Q1 		$25K Sell
8
-4
-33% -$163 ﹤0.01% 7283
2020
Q4 		$56K Sell
12
-107
-90% -$4.97K ﹤0.01% 6059
2020
Q3 		$554K Hold
119
– – ﹤0.01% 2861
2020
Q2 		$429K Buy
119
+85
+250% +$3.13K ﹤0.01% 3095
2020
Q1 		$120K Buy
34
+9
+36% +$368 ﹤0.01% 4177
2019
Q4 		$113K Buy
25
+18
+257% +$654 ﹤0.01% 4397
2019
Q3 		$17K Sell
7
-13
-65% -$326 ﹤0.01% 5931
2019
Q2 		$44K Buy
20
+19
+1,900% +$349 ﹤0.01% 4974
2019
Q1 		$1K Hold
1
– – ﹤0.01% 6949
2018
Q4 		$1K Buy
+1
New +$13 ﹤0.01% 6807

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Simplex Trading's ZYME Position: Q1 2026 in Review

Simplex Trading reduced its Zymeworks (ZYME) stake by 97% in Q1 2026, selling an estimated $1.11M and leaving 1,336 shares worth $33.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6278.

Simplex Trading first reported a position in ZYME in Q4 2018 and has held it in 25 quarters since. The position peaked at $1.79M in Q4 2019. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Simplex Trading held 1,336 shares of Zymeworks worth $33.5K as of Q1 2026.
  • Simplex Trading sold 46,704 Zymeworks shares in Q1 2026, an estimated $1.11M.
  • Zymeworks made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6278 holding.
  • Simplex Trading first reported a position in Zymeworks in Q4 2018 and has held it in 25 quarters since.
  • Simplex Trading's Zymeworks position peaked at $1.79M in Q4 2019.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.